comparemela.com
Home
Live Updates
Kathleen Bloch - Breaking News
Pages:
11
12
13
14
15
16
17
Page 10 - Kathleen Bloch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
United states
Efthymiosn deliargyris
Josephine kraus
Eric kim
Marcus schult
Michaelj mack
Kathleen bloch
Material command
European company contact
Cardiovascular service
European union
Baylor plano research center
Us army
Blood institute
National heart
Cytosorbents corporation
CytoSorbents Corporation (CTSO) Q3 2022 Earnings Call Transcript
CytoSorbents Corporation (NASDAQ:NASDAQ:CTSO) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Michelle Almonte - Executive Assistant to CEO Phillip Chan -.
United states
New jersey
France general
Bruxelles capitale
Richard whitlock
Zachary weiner
Christopher cramer
Josh jennings
Efthymios deliargyris
Vincent capponi
Kathleen bloch
Kathy bloch
Sean lee
Cytosorbents europe gmb
Zach weiner
Vince capponi
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
New jersey
United states
State of new jersey
Josephine kraus
Astra zeneca
Phillip chan
Marcus schult
Kathleen bloch
Janssen bayer
Us centers of disease
Department of defense
European company contact
Material command
Us national institutes of health
Turkish ministry of health
European association for cardio
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
New jersey
United states
State of new jersey
Josephine kraus
Astra zeneca
Phillip chan
Marcus schult
Kathleen bloch
Janssen bayer
Us centers of disease
Department of defense
European company contact
Material command
Us national institutes of health
Turkish ministry of health
European association for cardio
Enhanced Lung Rest with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U S Hospitals
/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.
France general
United states
Jw awori hayanga
Josephine kraus
Joerg scheier
Marcus schult
Kathleen bloch
Cytosorbents europe gmb
Eric kim
Robert bartlett
Phillip chan
Material command
Virginia university school of medicine
European union
Us army
Blood institute
vimarsana © 2020. All Rights Reserved.